(Stockholm, Sweden, September 29, 2021) Inhalation Sciences AB (ISAB) announces Today, it has commissioned Redeye to regularly, in-depth stock analysis of the company. The strategic goal is to increase ISAB’s market profile and visibility, so that investors and stakeholders can develop a better understanding of the business and its results and future prospects.
Redeye specializes in providing analyzes and insights about companies in the Nordic region’s fast-growing and innovative Life Science and Technology sector. Redeye’s first report on ISAB has now been published and is available on ISAB’s website, https://www.inhalation.se/investors/bolagsanalys/, and on Redeye’s website, www.redeye.se/company/inhalationsciences.
For more information on inhalation sciences, please contact:
Manoush Masarrat, VD
Email: [email protected]
Mobile: +46 (0) 73 628 9153
About Inhalations Sciences Sweden AB (publ)
Inhalation Science Sweden AB (publ) develops and commercializes world-leading inhalation research instruments and services. The company’s patented laboratory instruments PreciseInhale® and DissolvIt® enable researchers in the pharmaceutical industry to decide on drug pipeline at an early stage, saving time and resources for R&D departments and enabling researchers at academic institutions to define how aerosols and small particles affects our lungs, and so our health, when we inhale.
https://news.cision.com/inhalation-sciences/r/inhalation-sciences-announces-redeye-to-initiate-regular-stock-analysis-monitoring-of-the-company,c3422942
https://mb.cision.com/Main/15842/3422942/1474189.pdf
(c) 2021 Cision. All rights reserved., Source Press releases – English